| Magellan Global Equities Fund (Currency Hedged) (MHG) |
Financials |
$73 |
MHG - Quarterly Portfolio Disclosure - 30 June 2025
|
31 Jul 2025 9:49AM |
$3.980 |
$3.930 |
fallen by
1.26%
|
|
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$307 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:49AM |
$0.095 |
$0.730 |
risen by
668.42%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Starpharma continued the development and regulatory expansion of SPL7013 (VIRALEZE™) antiviral nasal spray.
- The company advanced dendrimer-based drug delivery and pharmaceutical product programs.
- Ongoing collaborations with international pharmaceutical partners were maintained.
- Regulatory submissions and reviews for VIRALEZE™ continued in multiple regions.
- Appendix 4C reported cash outflows primarily related to R&D and commercial activities.
- Starpharma maintained a strong cash position at quarter end.
- The report detailed operational, financial, and strategic progress for the quarter ended 31 March 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catalina Resources Ltd (CTN) ORDINARY FULLY PAID |
Materials |
$8 |
Catalina intersects wide gold zones in maiden drilling
|
31 Jul 2025 9:49AM |
$0.004 |
$0.046 |
risen by
1,050%
|
|
CTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Catalina Resources Ltd completed a maiden diamond drilling program at the CTN project.
- Eight drill holes totaling 1,180.5 meters were completed.
- Drilling targeted the El Tambo and La Maruja prospects.
- Wide gold mineralized zones were intersected in several drill holes.
- Significant gold grades and thicknesses were reported, including high-grade intervals.
- Results validate the geological model and support ongoing exploration activities.
- Plans are underway for further drilling to expand and define mineralized zones.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Burgundy Diamond Mines Limited (BDM) ORDINARY FULLY PAID |
Materials |
$24 |
Ekati Life of Mine Plan Update
|
31 Jul 2025 9:49AM |
$0.033 |
$0.017 |
fallen by
48.48%
|
|
BDM - Price-sensitive ASX Announcement
Full Release
Key Points
- BDM released an updated Ekati Life of Mine Plan in March 2024.
- The updated plan extends Ekati's mine life through to 2031.
- Ore reserves and resources have increased due to exploration and optimized mine planning.
- The plan outlines production forecasts, operational schedules, and capital expenditure estimates.
- Diamond output is expected to remain robust over the life of mine horizon.
- Strategic advancements have supported increased confidence in resource and reserve bases.
- Operational improvements and cost efficiencies are prioritized.
- Environmental responsibility and community engagement remain central to company strategy.
- The update includes an assessment of risks and opportunities for future growth.
- BDM is committed to sustainable development and long-term value creation for stakeholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Firstwave Cloud Technology Limited (FCT) ORDINARY FULLY PAID |
Information Technology |
$17 |
FY25 Q4 Activity Report and Appendix 4C
|
31 Jul 2025 9:49AM |
$0.015 |
$0.008 |
fallen by
46.67%
|
|
FCT - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong revenue growth and new contract wins in FY25 Q4.
- Continued expansion of recurring revenue base.
- Solid demand for cybersecurity products across partners and resellers.
- Ongoing investments in product development and strategic partnerships.
- Focus on cost management and operational efficiency.
- Improved sales pipeline and positive outlook for coming quarters.
- Appendix 4C details cash receipts, payments, and end-of-quarter cash position.
- Emphasis on maintaining adequate cash reserves and prudent capital allocation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Energy Metals Limited (EME) ORDINARY FULLY PAID |
Energy |
$16 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:48AM |
$0.085 |
$0.074 |
fallen by
12.94%
|
|
EME - Price-sensitive ASX Announcement
Full Release
Key Points
- EME maintained an active exploration and project development program across its uranium assets.
- The Bigrlyi Joint Venture remains the primary focus, with ongoing technical and environmental studies.
- Joint venture arrangements continue with Vimy Resources and Northern Territory Uranium Pty Ltd.
- Financial management remained cautious, with clear reporting on cash flows and expenditures.
- The company holds significant uranium tenements in both the Northern Territory and Western Australia.
- EME emphasized regulatory compliance and provided updates on tenement status.
- The report discusses broader market conditions and EME's readiness to capitalize on uranium sector improvements.
- No production or sales occurred during the quarter; activities centered on exploration and asset management.
- Appendix 5B details cash outflows and receipts for the quarter.
- EME retains a strong cash position to support ongoing project activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Critical Minerals Limited (ACM) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:48AM |
$0.057 |
$0.040 |
fallen by
29.82%
|
|
ACM - Price-sensitive ASX Announcement
Full Release
Key Points
- ACM advanced exploration across its critical mineral projects in Western Australia.
- The company focused on lithium, rare earths, and battery metals.
- Key projects included Cooletha, Rankin Dome, and Shaw.
- Activities involved soil sampling, mapping, and heritage surveys.
- Completion of the first drilling program at Cooletha with positive geochemical results.
- ACM listed on the ASX during the reporting period.
- Financial report includes summary of cash flows and exploration expenditure.
- ACM maintains sufficient funding for future exploration activities.
- No production or significant sales reported in the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hydrix Limited (HYD) ORDINARY FULLY PAID |
Information Technology |
$6 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:48AM |
$0.018 |
$0.004 |
fallen by
77.78%
|
|
HYD - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly revenue reached $3.3 million, up 47% from the previous quarter.
- Operating cash flow was positive at $0.5 million for the quarter.
- Revenue grew 32% compared to the prior corresponding period.
- Signed a distribution agreement for the AngelMed Guardian device in Taiwan.
- Medical and Engineering segments showed strong performance.
- Expansion of sales channels in Asia-Pacific region continued.
- Focus on innovative medical technology and cardiovascular portfolio.
- Investment in business development and sales capability.
- Cost management and improved cash position were prioritized.
- Report covers cash flows, investments, and related party transactions.
- Positive outlook expressed for the next quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$76 |
June 2025 Quarterly Activities and Cashflow Report
|
31 Jul 2025 9:46AM |
$0.070 |
$0.140 |
risen by
100%
|
|
PHO - Price-sensitive ASX Announcement
Full Release
Key Points
- Chaketma Bankable Feasibility Study advanced with technical workstreams ongoing.
- Pilot beneficiation and phosphoric acid test work continued.
- Progress made on resource drilling and environmental/permitting workstreams.
- Positive community and stakeholder engagement initiatives undertaken.
- Strong cash position reported at quarter end.
- No significant health, safety or environmental incidents occurred.
- Company focused on advancing Chaketma to production and progressing offtake and financing discussions.
- Quarterly cashflow report included with details on expenditure and cash balance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RemSense Technologies Limited (REM) ORDINARY FULLY PAID |
Industrials |
$7 |
Trading Halt
|
31 Jul 2025 9:46AM |
$0.034 |
$0.027 |
fallen by
20.59%
|
|
REM - Price-sensitive ASX Announcement
Full Release
Key Points
- RemSense Technologies Limited requested a trading halt on its securities.
- The trading halt is pending an announcement regarding a capital raising.
- The halt is intended to remain until 13 June 2024 or until the announcement is made.
- The request is made to ensure an orderly market.
- The announcement is in accordance with ASX Listing Rule requirements.
- The request was authorized by the company's Board of Directors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Halo Technologies Holdings Ltd (HAL) ORDINARY FULLY PAID |
Financials |
$5 |
June 2025 Quarterly Activities Report and Appendix 4C
|
31 Jul 2025 9:46AM |
$0.031 |
$0.016 |
fallen by
48.39%
|
|
HAL - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers operational and financial activities for the June 2025 quarter.
- Highlights achievements in product development and customer growth.
- Provides Appendix 4C cash flow statement including receipts, expenditures, and investment activities.
- Details on partnership activities and strategic initiatives.
- Continued focus on technology platform scaling and customer acquisition.
- Emphasis on prudent cost management.
- Management reiterates commitment to growth and shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Taruga Minerals Limited (TAR) ORDINARY FULLY PAID |
Materials |
$18 |
High Priority VTEM conductor identified at Thowagee
|
31 Jul 2025 9:45AM |
$0.009 |
$0.019 |
risen by
111.11%
|
|
TAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Taruga Minerals Limited identified a high-priority VTEM conductor at Thowagee.
- The VTEM anomaly coincides with observed copper mineralization at surface.
- The conductor is untested and presents a significant exploration target.
- Strong conductivity response and favorable geological setting enhance its potential.
- Taruga plans to undertake on-ground follow-up including geochemical sampling and potentially drilling.
- The discovery supports the company’s regional copper and critical minerals strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sun Silver Limited (SS1) ORDINARY FULLY PAID |
Materials |
$168 |
Cleansing Notice
|
31 Jul 2025 9:45AM |
$0.930 |
$0.915 |
fallen by
1.61%
|
|
| Papyrus Australia Limited (PPY) ORDINARY FULLY PAID |
Materials |
$6 |
Trading Halt
|
31 Jul 2025 9:45AM |
$0.009 |
$0.009 |
fallen by
0%
|
|
PPY - Price-sensitive ASX Announcement
Full Release
Key Points
- Papyrus Australia Limited (PPY) requested a trading halt on 11 June 2024.
- The trading halt was pending an announcement about a material capital raising.
- The halt will remain until the earlier of the announcement release or trading resumption on 13 June 2024.
- The purpose of the halt is to ensure a fully informed market and prevent uninformed trading.
- The request and the trading halt were granted by the ASX.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tamboran Resources Corporation (TBN) CDI 200:1 US PERSON PROHIBITED EXCLUDING QIB |
Energy |
$1,639 |
Change of Director's Interest Notice - Barrett
|
31 Jul 2025 9:45AM |
$0.160 |
$0.235 |
risen by
46.88%
|
|
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$332 |
Quarterly Activities Report
|
31 Jul 2025 9:43AM |
$1.305 |
$2.880 |
risen by
120.69%
|
|
BCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Beacon Minerals Limited reported gold production of 6,750 ounces for the quarter ending 30 September 2022.
- Gold sales totaled 7,375 ounces at an average price of $2,507 per ounce.
- The company acquired the MacPhersons Reward Project to enhance its resource base.
- Ongoing exploration and drilling at Jaurdi and nearby tenements continued during the quarter.
- Beacon maintained a cash balance of $17.2 million and continued to reduce debt.
- Focus remains on optimizing gold production, advancing exploration, and evaluating further acquisition opportunities.
- The report addresses environmental, permitting, and corporate governance updates relevant to ongoing operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tamboran Resources Corporation (TBN) CDI 200:1 US PERSON PROHIBITED EXCLUDING QIB |
Energy |
$1,639 |
Change of Director's Interest Notice - Siegel
|
31 Jul 2025 9:43AM |
$0.160 |
$0.235 |
risen by
46.88%
|
|
| Galilee Energy Limited (GLL) ORDINARY FULLY PAID |
Energy |
$13 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:42AM |
$0.011 |
$0.007 |
fallen by
36.36%
|
|
GLL - Price-sensitive ASX Announcement
Full Release
Key Points
- Operational update focuses on the Glenaras Gas Project, detailing drilling, completions, and production enhancement activities.
- Horizontal well performance and pressure build-up monitoring are ongoing, with efforts to improve gas production rates.
- Galilee Energy Limited received $3.0 million in funding from the Queensland Government’s Frontier Gas grant.
- The company is actively engaged in a farm-out process for the Glenaras Gas Project.
- The quarterly report includes Appendix 5B, outlining cash inflows, outflows, and the closing cash balance of $12.1 million.
- Exploration and evaluation expenditure for the quarter was $4.1 million.
- No production revenue was reported for the current quarter.
- The company has a strong cash position and no debt.
- Ongoing stakeholder and regulatory engagement continues to support project advancement.
- No payments to related parties were made except for directors’ fees.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Blue Star Helium Limited (BNL) ORDINARY FULLY PAID |
Energy |
$37 |
Aloha Mula 12 Flow Test Results Lincoln County
|
31 Jul 2025 9:42AM |
$0.006 |
$0.006 |
fallen by
0%
|
|
BNL - Price-sensitive ASX Announcement
Full Release
Key Points
- Blue Star Helium Limited released results from the Aloha Mula 12 flow test in Lincoln County, Colorado.
- The well demonstrated positive helium concentrations and robust gas flows.
- Test results exceeded expectations and support plans for commercial development.
- Key flow data will inform future production and infrastructure planning.
- The company continues to assess and appraise assets for further helium production.
- The announcement marks progress towards commercial helium operations in the area.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ClearVue Technologies Limited (CPV) ORDINARY FULLY PAID |
Industrials |
$30 |
ClearVue to host Investor Update
|
31 Jul 2025 9:42AM |
$0.230 |
$0.085 |
fallen by
63.04%
|
|
| OzAurum Resources Limited (OZM) ORDINARY FULLY PAID |
Materials |
$25 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:42AM |
$0.068 |
$0.087 |
risen by
27.94%
|
|
OZM - Price-sensitive ASX Announcement
Full Release
Key Points
- Focused on advancing Mulgabbie North and Patricia Gold Projects in Western Australia.
- Conducted reverse circulation (RC) and diamond drilling at Mulgabbie North, yielding significant gold intercepts.
- Completed geological and geophysical studies to support exploration strategy.
- Held a cash balance of $2.5 million as at 31 March 2023.
- No mining production or development activities occurred during the quarter.
- Planned further drilling and exploration activities for the upcoming quarter.
- Expenditure was primarily on exploration activities.
- Confirmed compliance with ASX listing rules.
- Outlined related party payments in accordance with ASX requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tamboran Resources Corporation (TBN) CDI 200:1 US PERSON PROHIBITED EXCLUDING QIB |
Energy |
$1,639 |
Change of Director's Interest Notice - Dalton
|
31 Jul 2025 9:42AM |
$0.160 |
$0.235 |
risen by
46.88%
|
|
| Strategic Energy Resources Limited (SER) ORDINARY FULLY PAID |
Materials |
$10 |
Proposed issue of securities - SER
|
31 Jul 2025 9:41AM |
$0.007 |
$0.155 |
risen by
2,114.29%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$41 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:41AM |
$0.280 |
$0.098 |
fallen by
65%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report covers the period ending March 31, 2024.
- Imugene is advancing multiple immuno-oncology clinical trials including HER-Vaxx, PD1-Vaxx, and onCARlytics.
- Key clinical milestones achieved include patient dosing and regulatory approvals.
- The company reports a robust cash balance at quarter's end.
- Operational expenditures are closely managed to support the clinical development pipeline.
- Upcoming milestones include further patient recruitment and trial readouts.
- Imugene remains focused on developing new cancer immunotherapies.
- The report includes the Appendix 4C Cash Flow statement showing detailed financial movements for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$212 |
Application for quotation of securities - ARR
|
31 Jul 2025 9:41AM |
$0.320 |
$0.365 |
risen by
14.06%
|
|
Call 1300 880 160
Start a chat
Schedule a call
